Reducción la colonización bacteriana de los drenajes quirúrgicos después de operaciones mamarias y axilares

1. Prospero E, Cavicchi A, Bacelli S, et al. Surveillance for surgical site infection after hospital discharge: a surgical procedure-specific perspective. Infect Control Hosp Epidemiol. 2006;27:1313–1317.
2. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37:783–805.
3. Nahabedian MY, Tsangaris T, Momen B, et al. Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg. 2003;112:467–476.
4. Ruvalcaba-Limon E, Robles-Vidal C, Poitevin-Chacon A, et al. Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case-control analysis. Breast Cancer Res Treat. 2006;95:147–152.
5. Vilar-Compte D, Jacquemin B, Robles-Vidal C, et al. Surgical site infections in breast surgery: case-control study. World J Surg. 2004;28:242–246.
6. El-Tamer MB, Ward BM, Schifftner T, et al. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007;245:665–671.
7. Olsen MA, Lefta M, Dietz JR, et al. Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 2008;207:326–335.
8. de Blacam C, Ogunleye AA, Momoh AO, et al. High body mass index and smoking predict morbidity in breast cancer surgery: a multivariate analysis of 26,988 patients from the national surgical quality improvement program database. Ann Surg. 2012;255:551–555.
9. Rey JE, Gardner SM, Cushing RD. Determinants of surgical site infection after breast biopsy. Am J Infect Control. 2005;33:126–129.
10. Rotstein C, Ferguson R, Cummings KM, et al. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect Control Hosp Epidemiol. 1992;13:207–214.
11. Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc. 2011;86:1113–1123.
12. Barie PS. Multidrug-resistant organisms and antibiotic management. Surg Clin North Am. 2012;92:345–391, ix–x.
13. Throckmorton AD, Boughey JC, Boostrom SY, et al. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol. 2009;16:2464–2469.
14. Throckmorton AD, Boostrom SY, Hoskin TL, et al. Surgical site infection (SSI) after breast surgery: How good is the CDC definition? Ann Surg Oncol. 2008;15(suppl 2):38.
15. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305–1309.
16. Center for Disease Control and Prevention. Preventing healthcare-associated infections. Available at: http://www.cdc.gov/HAI/prevent/prevention.html. Accessed May 20, 2012.
17. The Joint Commission. Surgical care improvement project. Available at: http://www.jointcommission.org/surgical_care_improvement_project. Accessed May 20, 2012.
18. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25:3657–3663.
19. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599–609.
20. Degnim AC, Throckmorton AD, Boostrom SY, et al. Surgical site infection (SSI) after breast surgery: impact of 2010 CDC reporting guidelines [published online ahead of print June 26, 2012]. Ann Surg Oncol. 2012;19:4099–4103. doi:10.1245/s10434-012-2448-6.
21. Weiss CA III, Statz CL, Dahms RA, et al. Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg. 1999;134:1041–1048.
22. Felippe WA, Werneck GL, Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg. 2007;31:2293–2299.
23. Tadych K, Donegan WL. Postmastectomy seromas and wound drainage. Surg Gynecol Obstet. 1987;165:483–487.
24. Gupta R, Pate K, Varshney S, et al. A comparison of 5-day and 8-day drainage following mastectomy and axillary clearance. Eur J Surg Oncol. 2001;27:26–30.
25. Somers RG, Jablon LK, Kaplan MJ, et al. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer. A prospective randomized trial. Ann Surg. 1992;215:146–149.
26. Boostrom SY, Throckmorton AD, Boughey JC, et al. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg. 2009;208:148–150.
27. Brahmbhatt RD, Huebner M, Scow JS, et al. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons [published online ahead of print July 6, 2012]. Ann Surg Oncol. 2012;19:3205–3211. doi:10.1245/s10434-012-2477-1.
28. Phillips BT, Wang ED, Mirrer J, et al. Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care. Ann Plast Surg. 2011;66(5):460–465.
29. Landes G, Harris PG, Lemaine V, et al. Prevention of surgical site infection and appropriateness of antibiotic prescribing habits in plastic surgery. J Plast Reconstr Aesthet Surg. 2008;61:1347–1356.
30. Throckmorton AD, Hoskin T, Boostrom SY, et al. Complications associated with postoperative antibiotic prophylaxis after breast surgery. Am J Surg. 2009;198:553–556.
31. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis. 2002;34:1232–1242.
32. O'Grady NP, Alexander M, Burns LA, et al. Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:1087–1099.
33. Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301:1231–1241.
34. Levy I, Katz J, Solter E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J. 2005;24:676–679.
35. Washington EA. Instillation of 3% hydrogen peroxide or distilled vinegar in urethral catheter drainage bag to decrease catheter-associated bacteriuria. Biol Res Nurs. 2001;3:78–87.
36. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg. 1985;120:267–270.
37. McKenna PJ, Lehr GS, Leist P, et al. Antiseptic effectiveness with fibroblast preservation. Ann Plast Surg. 1991;27:265–268.
38. Doughty D. A rational approach to the use of topical antiseptics. J Wound Ostomy Continence Nurs. 1994;21:224–231